+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Drug Delivery Devices Global Market Report 2023

  • PDF Icon

    Report

  • 250 Pages
  • February 2023
  • Region: Global
  • The Business Research Company
  • ID: 5733801
UP TO OFF until Dec 31st 2023

Quick Summary:

As global healthcare needs continue to evolve, the drug delivery devices market presents a unique opportunity for strategic investment. With advancements in the field driving increased demand and growth, our comprehensive market report provides crucial insights to successfully navigate this industry ruled by innovation.

Our research reveals the significant impact of rising chronic disease prevalence on the market, closely analyzing how these trends shape the needs and expectations in patient care settings, and the innovative solutions offered by top players in the industry. With insights on the substantial influence of regulatory changes, along with novel technologies like the microneedle drug delivery system, this report offers a thorough understanding of the dynamics at play. You'll gain exclusive access to key industry collaborations that are reshaping the marketplace. It's clear that navigating this promising yet complex industry requires a well-informed strategy. Let our report be your guide.

The global drug delivery devices market will grow from $81.13 billion in 2022 to $87.65 billion in 2023 at a compound annual growth rate (CAGR) of 8.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The drug delivery devices market is expected to grow from $115.09 billion in 2027 at a CAGR of 7.0%.

The drug delivery devices market consists of sales of instruments such as smart pills, inhalers and nebulizers, drug-eluting stents, safety syringes, and transdermal patches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Drug delivery devices are used for delivering specific drugs to a specific part of the body to cure diseases. Drug delivery devices used in various patient care settings such as hospitals, diagnostic centres, clinics, and home care settings are included in this market.

North America was the largest region in the drug delivery devices market in 2022. Asia Pacific was the second-largest region in the drug delivery devices market. The regions covered in drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main route of administration of drug delivery devices is oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery, and implantable drug delivery. Oral drug delivery is a route of drug delivery in which a tablet or capsule is administered into the alimentary canal of a human being. The patient care setting is hospitals, diagnostic centres, ambulatory surgery centres/clinics, home care settings, and others. The various applications involved are cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases, autoimmune diseases, central nervous system disorders, and others.

The rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer and other diseases is expected to drive the drug delivery devices market. According to the world health organization (WHO), by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide, and 71% of deaths due to ischemic heart disease (IHD), 75% of deaths due to stroke, and 70% of deaths due to diabetes will occur in developing countries. There are various routes of drug administration for medical drugs. The selection of the route depends on three factors - the effect desired; the type of the disease and the type of the product. Currently, the development of new drug delivery systems plays a major role in the pharmaceutical industry. Research and development (R&D) in drug delivery are increasing throughout the world due to the increasing prevalence of these diseases. Most pharmaceutical companies are focusing on multiple drug delivery technologies for creating excellent advantages and better outcomes for their marketed products. Hence, the increasing prevalence of chronic diseases is resulting in increased consumption of therapeutic drugs and therapies, and this factor is expected to act as a driver for the growth of the drug delivery devices market.

The regulatory changes related to medical devices is expected to restrain the growth of the drug delivery devices market. The companies operating in the market are required to adapt according to the changes in the regulatory framework, which may limit business at the bottom line. Also, companies will have to bear the heavy cost of adapting to the changing regulatory framework. Also, the sudden changes in the regulatory framework related to medical devices can result in losses, fines, and penalties at a global level. The new MDSAP will come into effect in 2020 and is adopted by regulators in the US, Canada, Japan, Brazil, and Australia. Following the changes, in Canada, all the medical device manufacturers including drug delivery products manufacturers, will have to comply with the requirements of MDSAP and are required to submit the MDSAP reports to the regulatory body in order to obtain or maintain the device licenses, resulting in high costs and time loss. Thus, the growth of the drug delivery devices market is limited by the regulatory changes related to medical devices.

The microneedle (MN), is a highly efficient and versatile medical device technology, due to its prominent properties including painless penetration, low cost, excellent therapeutic efficacy, and relative safety. The major players operating in the global microneedle drug delivery system include 3M, Vetter Pharma International GmbH, nano Biosciences LLC, Nano Pass and more. The microneedles are fabricated using biodegradable polymers in which drugs or vaccines are encapsulated in the microneedles. Once, the microneedles dissolve in the skin, the drug gets released. This novel delivery method allows a wider variety of molecules to pass the skin’s barrier, thus allowing the transdermal delivery to be applied to a large range of clinical applications, including diabetes, severe osteoporosis, and influenza vaccination.

Companies in the drug delivery devices market are collaborating with other companies within the industry in order to strengthen their product portfolio as well as expand their footprint across different geographies. For example, in October 2022, Nemera, a French pharmaceuticals company, partnered with Zollner Elektronik AG to develop electronic drug delivery systems. Zollner would provide its design, development, and manufacturing capabilities to help Nemera develop electronic drug delivery system.

In August 2020, Sulzer, a Swiss-based engineering and manufacturing firm acquired Haselmeier GmbH for $118m. The acquisition of Haselmeier will allow Sulzer to complement its healthcare portfolio, in addition to leveraging its APS expertise in precision injection moulding to expand its presence in the drug delivery devices market. Haselmeier GmbH, a Swiss-German drug delivery device developer and manufacturer.

The countries covered in the drug delivery devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).

The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.

The drug delivery devices market research report is one of a series of new reports that provides drug delivery devices market statistics, including drug delivery devices industry global market size, regional shares, competitors with a drug delivery devices market share, detailed drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the drug delivery devices industry. This drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Major players in the drug delivery devices market are F. Hoffmann-La Roche Ltd, 3M Company, Pfizer Inc, Baxter International, BD, Novartis AG, Gerresheimer AG, Johnson & Johnson Services, Inc, Bayer AG, and GlaxoSmithKline plc.



This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary

2. Drug Delivery Devices Market Characteristics

3. Drug Delivery Devices Market Trends And Strategies

4. Drug Delivery Devices Market - Macro Economic Scenario
4.1 COVID-19 Impact On Drug Delivery Devices Market
4.2 Ukraine-Russia War Impact On Drug Delivery Devices Market
4.3 Impact Of High Inflation On Drug Delivery Devices Market

5. Drug Delivery Devices Market Size And Growth
5.1. Global Drug Delivery Devices Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Drug Delivery Devices Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Drug Delivery Devices Market Segmentation
6.1. Global Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Ocular Drug Delivery
  • Pulmonary Drug Delivery
  • Nasal Drug Delivery
  • Transmucosal Drug Delivery
  • Implantable Drug Delivery
6.2. Global Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers/Clinics
  • Home Care Settings
  • Other Patient Care Settings
6.3. Global Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Cancer
  • Infectious Diseases
  • Respiratory Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Central Nervous System Disorders
  • Other Applications
7. Drug Delivery Devices Market Regional And Country Analysis
7.1. Global Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Drug Delivery Devices Market
8.1. Asia-Pacific Drug Delivery Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Drug Delivery Devices Market
9.1. China Drug Delivery Devices Market Overview
9.2. China Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Drug Delivery Devices Market
10.1. India Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Drug Delivery Devices Market
11.1. Japan Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Drug Delivery Devices Market
12.1. Australia Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Drug Delivery Devices Market
13.1. Indonesia Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Drug Delivery Devices Market
14.1. South Korea Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Drug Delivery Devices Market
15.1. Western Europe Drug Delivery Devices Market Overview
15.2. Western Europe Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Drug Delivery Devices Market
16.1. UK Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Drug Delivery Devices Market
17.1. Germany Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Drug Delivery Devices Market
18.1. France Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Drug Delivery Devices Market
19.1. Eastern Europe Drug Delivery Devices Market Overview
19.2. Eastern Europe Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Drug Delivery Devices Market
20.1. Russia Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Drug Delivery Devices Market
21.1. North America Drug Delivery Devices Market Overview
21.2. North America Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Drug Delivery Devices Market
22.1. USA Drug Delivery Devices Market Overview
22.2. USA Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Drug Delivery Devices Market
23.1. South America Drug Delivery Devices Market Overview
23.2. South America Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Drug Delivery Devices Market
24.1. Brazil Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Drug Delivery Devices Market
25.1. Middle East Drug Delivery Devices Market Overview
25.2. Middle East Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Drug Delivery Devices Market
26.1. Africa Drug Delivery Devices Market Overview
26.2. Africa Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Drug Delivery Devices Market Competitive Landscape And Company Profiles
27.1. Drug Delivery Devices Market Competitive Landscape
27.2. Drug Delivery Devices Market Company Profiles
27.2.1. BD/Becton, Dickinson
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Novartis AG
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Pfizer Inc
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Johnson & Johnson Services, Inc
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Gerresheimer AG
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Drug Delivery Devices Market

29. Drug Delivery Devices Market Future Outlook and Potential Analysis

30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Historic And Forecast Inflation Rates
30.4. Research Inquiries
30.5. About the Publisher
30.6. Copyright And Disclaimer

Executive Summary

Drug Delivery Devices Global Market Report 2023 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Where is the largest and fastest growing market for drug delivery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug delivery devices market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered

1) By Route Of Administration: Oral Drug Delivery; Injectable Drug Delivery; Topical Drug Delivery; Ocular Drug Delivery; Pulmonary Drug Delivery; Nasal Drug Delivery; Transmucosal Drug Delivery; Implantable Drug Delivery
2) By Patient Care Setting: Hospitals; Diagnostic Centers; Ambulatory Surgery Centers/Clinics; Home Care Settings; Other Patient Care Settings
3) By Application: Cancer; Infectious Diseases; Respiratory Diseases; Diabetes; Cardiovascular Diseases; Autoimmune Diseases; Central Nervous System Disorders; Other Applications

Companies Mentioned: F. Hoffmann-La Roche Ltd.; 3M Company; Pfizer Inc.; Baxter International; BD.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • F. Hoffmann-La Roche Ltd.
  • 3M Company
  • Pfizer Inc.
  • Baxter International
  • BD.
  • Novartis AG
  • Gerresheimer AG
  • Johnson & Johnson Services, Inc.
  • Bayer AG
  • GlaxoSmithKline plc
  • B. Braun Melsungen AG
  • Cipla Inc.
  • Boehringer Ingelheim
  • Antares Pharma
  • Sulzer Ltd.
  • Sanofi
  • Novosanis
  • MEDMIX SYSTEMS AG
  • Merck & Co., Inc.
  • Insulet Corporation
  • OraSure Technologies, Inc.
  • Enable Injections
  • West Pharmaceutical Services, Inc.
  • SMC Ltd.
  • ViVO Smart Medical Devices Ltd.
  • Smith Medical
  • CareFusion Corporation
  • Abbott Laboratories
  • Nipro Corporation
  • Allergan
  • Catalent

Methodology

Loading
LOADING...